Active Ingredient: Sildenafil
Treatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
30 - 60 mg
From 10 To 20 mg 3 time(s) per day every day for 30 day(s)
30 mg
For paediatric patients aged 1 year to 17 years old, the recommended dose in patients ≤20 kg is 10mg three times a day and for patients >20 kg is 20mg three times a day. Higher than recommended doses should not be used in paediatric patients with PAH. The 20mg tablet should not be used in cases where 10mg TID should be administered in younger patients. Other pharmaceutical forms are available for administration to patients ≤20 kg and other younger patients who are not able to swallow tablets.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
